184 related articles for article (PubMed ID: 35926360)
1. Montreal Cognitive Assessment (MoCA) and Digit Symbol Substitution Test (DSST) as a screening tool for evaluation of cognitive deficits in schizophrenia.
Daderwal MC; Sreeraj VS; Suhas S; Rao NP; Venkatasubramanian G
Psychiatry Res; 2022 Oct; 316():114731. PubMed ID: 35926360
[TBL] [Abstract][Full Text] [Related]
2. The use of the Montreal Cognitive Assessment (MoCA) screening tool to evaluate cognitive deficits in Lebanese in-patients with schizophrenia.
Haddad C; Salameh P; Sacre H; Clément JP; Calvet B
Asian J Psychiatr; 2022 Apr; 70():103029. PubMed ID: 35189473
[TBL] [Abstract][Full Text] [Related]
3. Utility of the MoCA for cognitive impairment screening in long-term psychosis patients.
Gil-Berrozpe GJ; Sánchez-Torres AM; García de Jalón E; Moreno-Izco L; Fañanás L; Peralta V; Cuesta MJ;
Schizophr Res; 2020 Feb; 216():429-434. PubMed ID: 31801676
[TBL] [Abstract][Full Text] [Related]
4. Montreal Cognitive Assessment as a screening instrument for cognitive impairments in schizophrenia.
Yang Z; Abdul Rashid NA; Quek YF; Lam M; See YM; Maniam Y; Dauwels J; Tan BL; Lee J
Schizophr Res; 2018 Sep; 199():58-63. PubMed ID: 29549976
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in SLE.
Raghunath S; Glikmann-Johnston Y; Morand E; Stout JC; Hoi A
Lupus Sci Med; 2021 Dec; 8(1):. PubMed ID: 34911821
[TBL] [Abstract][Full Text] [Related]
6. Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery.
Bezdicek O; Michalec J; Kališová L; Kufa T; Děchtěrenko F; Chlebovcová M; Havlík F; Green MF; Nuechterlein KH
Schizophr Res; 2020 Apr; 218():85-92. PubMed ID: 32089475
[TBL] [Abstract][Full Text] [Related]
7. Methods for Improving Screening for Vascular Cognitive Impairment Using the Montreal Cognitive Assessment.
Zaidi KB; Rich JB; Sunderland KM; Binns MA; Truong L; McLaughlin PM; Pugh B; Kwan D; Beaton D; Levine B; Sahlas DJ; Dowlatshahi D; Hassan A; Mandzia J; ; Troyer AK; Swartz RH
Can J Neurol Sci; 2020 Nov; 47(6):756-763. PubMed ID: 32522309
[TBL] [Abstract][Full Text] [Related]
8. Screening for cognitive impairment with the Montreal Cognitive Assessment in Chinese patients with acute mild stroke and transient ischaemic attack: a validation study.
Zuo L; Dong Y; Zhu R; Jin Z; Li Z; Wang Y; Zhao X; Sachdev P; Zhang W; Wang Y
BMJ Open; 2016 Jul; 6(7):e011310. PubMed ID: 27406642
[TBL] [Abstract][Full Text] [Related]
9. Validation of the Turkish Version of the Montreal Cognitive Assessment Scale (MoCA-TR) in patients with Parkinson's disease.
Ozdilek B; Kenangil G
Clin Neuropsychol; 2014; 28(2):333-43. PubMed ID: 24528299
[TBL] [Abstract][Full Text] [Related]
10. Validity of the Montreal Cognitive Assessment Screener in Adolescents and Young Adults With and Without Congenital Heart Disease.
Pike NA; Poulsen MK; Woo MA
Nurs Res; 2017; 66(3):222-230. PubMed ID: 28448372
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the Quick Mild Cognitive Impairment (Qmci) screen to the Montreal Cognitive Assessment (MoCA) in an Australian geriatrics clinic.
Clarnette R; O'Caoimh R; Antony DN; Svendrovski A; Molloy DW
Int J Geriatr Psychiatry; 2017 Jun; 32(6):643-649. PubMed ID: 27427212
[TBL] [Abstract][Full Text] [Related]
12. Montreal Cognitive Assessment for evaluating the cognitive impairment in patients with schizophrenia: A systematic review.
Rosca EC; Cornea A; Simu M
Gen Hosp Psychiatry; 2020; 65():64-73. PubMed ID: 32502879
[TBL] [Abstract][Full Text] [Related]
13. Improving screening for vascular cognitive impairment at three to six months after mild ischemic stroke and transient ischemic attack.
Dong Y; Slavin MJ; Chan BP; Venketasubramanian N; Sharma VK; Collinson SL; Sachdev PS; Chen CL
Int Psychogeriatr; 2014 May; 26(5):787-93. PubMed ID: 24423626
[TBL] [Abstract][Full Text] [Related]
14. Validity of Montreal Cognitive Assessment to Detect Cognitive Impairment in Individuals with Type 2 Diabetes.
Gupta A; Goyal A; Rajan R; Vishnu VY; Kalaivani M; Tandon N; Srivastava MVP; Gupta Y
Diabetes Ther; 2024 May; 15(5):1155-1168. PubMed ID: 38520603
[TBL] [Abstract][Full Text] [Related]
15. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
[TBL] [Abstract][Full Text] [Related]
16. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
17. Screening for cognitive impairment in older adults with hematological malignancies using the Montreal Cognitive Assessment and neuropsychological testing.
Koll TT; Sheese AN; Semin J; Ernst W; High R; Wildes TM; Fisher A; Murman DL
J Geriatr Oncol; 2020 Mar; 11(2):297-303. PubMed ID: 31831362
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Rapid Cognitive Screen against Montreal Cognitive Assessment in screening for cognitive impairment in the old and old-old.
Chen MZ; Chan YH; Wong MWK; Merchant RA
Psychogeriatrics; 2022 Jul; 22(4):460-468. PubMed ID: 35577347
[TBL] [Abstract][Full Text] [Related]
19. Screening for cognitive impairment in non-affective psychoses: A comparison between the SCIP and the MoCA.
Belvederi Murri M; Folesani F; Costa S; Biancosino B; Colla C; Zerbinati L; Caruso R; Nanni MG; Purdon SE; Grassi L
Schizophr Res; 2020 Apr; 218():188-194. PubMed ID: 31948897
[TBL] [Abstract][Full Text] [Related]
20. Examining the Vietnamese Montreal cognitive assessment in healthy and moderate-to-severe traumatic brain injury populations.
Quang H; Nguyen AL; Do C; McDonald S; Nguyen C
Clin Neuropsychol; 2023 Jul; 37(5):1062-1077. PubMed ID: 36722174
[No Abstract] [Full Text] [Related]
[Next] [New Search]
